By providing a comprehensive breakdown of current products, product pipelines and clinical & regulatory events, Revere Healthcare™ provides content managers a wealth of focused and organized data on biopharmaceutical and medical technology companies.

---

The Revere Healthcare™ datafeed provides ongoing coverage on three types of events:
New Drug Application (NDA)/Biologic License Application (BLA) Filings, FDA Advisory Meetings, and Prescription Drug User Fee Act (PDUFA) Dates.

Relying on Revere’s proprietary drug database that tracks the pipeline of all US- and Canadian-listed biopharmaceutical and medical technology companies, the real-time Revere Healthcare™ datafeed offers unmatched tracking capability.

Revere Healthcare™ includes the following key information:

• Tradename and generic name of each drug candidate
• Name and ticker of the drug/device developer(s)
• Indication(s) seeking FDA approval
• Drug/candidate primary mechanism of action (PMOA)
• Revere Hierarchy™ location of the relevant drugs/device
• Directly competing drugs/devices that are either approved or in late clinical stage of development
• Complete data on filings, meetings and dates for over three years.